|
|
| Research article summary (published 4 Mar 2009): |
Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.
Full Abstract
BACKGROUND: Depressive disorders are associated with immune system alterations that can be detected in the blood. Cytokine concentrations in cerebrospinal fluid (CSF) and their relationship to aspects of suicidality have previously not been investigated. METHODS: We measured interleukin-1beta, interleukin-6 (IL-6), interleukin-8, and tumor necrosis factor-alpha (TNF-alpha) in CSF and plasma of suicide attempters (n = 63) and healthy control subjects (n = 47). Patients were classified according to diagnosis and violent or nonviolent suicide attempt. We evaluated suicidal ideation and depressive symptoms using the Suicide Assessment Scale and the Montgomery-Asberg Depression Rating Scale (MADRS). We also analyzed the relation between cytokines and monoamine metabolites 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) in CSF, as well as the integrity of the blood-brain barrier as reflected by the CSF:serum albumin ratio. RESULTS: IL-6 in CSF was significantly higher in suicide attempters than in healthy control subjects. Patients who performed violent suicide attempts displayed the highest IL-6. Furthermore, there was a significant positive correlation between MADRS scores and CSF IL-6 levels in all patients. IL-6 and TNF-alpha correlated significantly with 5-HIAA and HVA in CSF, but not with MHPG. Cytokine levels in plasma and CSF were not associated, and patients with increased blood-brain barrier permeability did not exhibit elevated cytokine levels. CONCLUSIONS: We propose a role for CSF IL-6 in the symptomatology of suicidal behavior, possibly through mechanisms involving alterations of dopamine and serotonin metabolism.
Author information
Author/s: Lindqvist, Daniel (D); Janelidze, Shorena (S); Hagell, Peter (P); Erhardt, Sophie (S); Samuelsson, Martin (M); Minthon, Lennart (L); Hansson, Oskar (O); Björkqvist, Maria (M); Träskman-Bendz, Lil (L); Brundin, Lena (L);
Affiliation: Department of Clinical Sciences, Section of Psychiatry, Lund University Hospital, Lund SE-221 85, Sweden.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Biological psychiatry (Biol Psychiatry), published in United States. (Language: eng)
Reference: 2009-Aug; vol 66 (issue 3) : pp 287-92
Dates: Created 2009/07/06; Completed 2009/10/13;
PMID: 19268915, status: MEDLINE (last retrieval date: 10/13/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Central noradrenergic function in man: vanillylmandelic acid in CSF.
3 Dec 1975 - Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders.
29 Jun 1978 - CSF monoamine metabolites in depression and schizophrenia.
30 Jan 1980 - Cortisol in the CSF of depressed and suicidal patients.
29 Jun 1980 - Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
13 Sep 2004 - Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding.
30 Dec 1985 - Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
30 Jan 1981 - Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites.
30 Aug 1977 - Cerebrospinal fluid amine metabolites in affective illness and schizophrenia: clinical and pharmacological studies.
30 Dec 1974 - Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
30 Mar 1984
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.